Skip to main content

Table 1 HLH/MAS Evidence-Based Guideline Entry Criteria

From: Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome

Clinical and Laboratory Criteria
1. Fever (high, unremitting)
2. Ferritin (≥500 ng/mL)
3. Other Considerations
 Rheumatologic/hematologic/immunologic conditions that predispose to HLH/MASa
 Neurologic symptomsb
 HSM
 Cytopeniasc
 Hepatobiliary dysfunctiond
 DIC
 EBV or other viral infection
  1. HLH hemophagocyticlymphohistiocytosis, MAS macrophage activation syndrome, HSM hepatosplenomegaly, DIC disseminated intravascular coagulation, EBV Epstein-Barr virus
  2. aIncluding but not limited to systemic juvenile idiopathic arthritis, systemic lupus erythematosus, Kawasaki Disease, familial HLH, lymphoma, Chediak-Higashi Syndrome, Griscelli Syndrome, Hermansky-Pudlak Syndrome type 2, X-linked lymphoproliferative disease 1 & 2
  3. bHeadaches, cognitive changes, focal examination findings, seizures, findings not explained by degree of illness/medications
  4. cHemoglobin < 9 g/dL, platelets < 200 109/L, absolute neutrophil count < 1000/mm3
  5. dElevated liver function tests or bilirubin
Back to article page

Pediatric Rheumatology

ISSN: 1546-0096